Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

532 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)

NCT04891770

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus N, Denmark
View all 26 locations
View Trial Details
Completed

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

NCT04439539

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Ruane Clinical Research Group Inc Los Angeles, California, United States
  • UPMC Center For Liver Diseases Pittsburgh, Pennsylvania, United States
  • Liver Institute Northwest Seattle, Washington, United States
  • University of Calgary Calgary, Alberta, Canada
View all 47 locations
View Trial Details
Completed

A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection

NCT05123599

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • UZ Antwerpen Edegem, Belgium
  • UZA-SGS Edegem, Belgium
  • Hopital Beaujon Clichy, France
  • Hopital de La Croix Rousse Lyon, France
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B

NCT05828745

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • First Hospital of Jilin University Changchun, Jilin, China
  • PCRN Trials Limited, trading as PCRN Auckland, Level 2, 2 Fred Thomas Drive, Takapuna, Auckland, 0622, New Zealand (hereinafter referred to as "Institution") Auckland, New Zealand
View Trial Details
Completed

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

NCT05275023

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Toronto General Hospital Toronto, Ontario, Canada
  • Fakultni nemocnice Hradec Kralove Hradec Králové, Czechia
  • IKEM Prague, Czechia
  • Hopital Beaujon Clichy, France
View all 26 locations
View Trial Details

Related conditions